Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

FIGS Shares Decline After Oppenheimer Downgrade

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Finance_ Trading ratings today (2)
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

FIGS shares experienced a decline in trading following a downgrade by Oppenheimer on March 8, 2024. The stock was shifted from an “outperform” rating to a “market perform” rating, with the removal of a $9 price target. As a result, FIGS Inc. saw a 7.5% drop in stock value during early trading on Monday.

FIGS Stock Shows Modest Increase on March 8, 2024, Near 52-Week Low and Below 200-Day Moving Average

FIGS stock had a mixed performance on March 8, 2024, as it traded near the bottom of its 52-week range and below its 200-day simple moving average. The price of FIGS shares increased by $0.00 since the market last closed, representing a modest 0.09% rise. The stock opened at $5.19 on March 8, which was $0.17 lower than its previous close. This lower opening price may have been a result of market factors or investor sentiment. FIGS, a company that specializes in medical apparel, has had a volatile stock performance in recent months. Despite trading near the bottom of its 52-week range, the stock has shown some resilience with a slight increase on March 8. Investors may be keeping a close eye on FIGS stock to see if it can maintain its momentum and potentially move back towards its 200-day simple moving average. The performance of FIGS stock on March 8 may be an indication of how the stock will fare in the coming days and weeks. Investors should conduct their own research and analysis before making any investment decisions. Stock prices can be influenced by a variety of factors, and past performance is not always indicative of future results.

FIGS Inc. (FIGS) Reports Strong Financial Performance with Revenue Reaching $545.65 Million

On March 8, 2024, FIGS Inc. (FIGS) showed strong financial performance with total revenue reaching $545.65 million over the past year and $144.92 million in the fourth quarter. Net income for FIGS was reported at $22.64 million over the past year and $10.00 million in the fourth quarter. Earnings per share (EPS) for FIGS stood at $0.12 over the past year and $0.05 in the fourth quarter. Overall, FIGS demonstrated solid financial performance on March 8, 2024, with steady revenue growth, improved net income, and increasing earnings per share. Investors may view these positive financial indicators as a sign of a healthy and growing company, potentially leading to an increase in the stock price. It will be interesting to see how FIGS continues to perform in the future and whether it can sustain its growth momentum.

Tags: FIGS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Investment (2)

Truist Securities Analyst Maintains Hold Rating on Vornado Realty with Revised Price Target

Technology Artificial intelligence Markets and money

Baidus Stock Soars with Launch of Chinas First 247 Robotaxi Service

Investings on laptops and finances

The Power of Investing A Case Study with SP Global

Recommended

Biotechnology Market Capitalization

Analyst Upgrades Price Target for Nuvation Bio to 5

2 years ago
CryoLife Stock

Medical Device Specialist Artivion Maintains Strong Analyst Backing

3 months ago
Walgreens Boots Alliance Stock

Walgreens Concludes Public Trading Era Following Landmark Acquisition

3 months ago
MA stock news

Analysis of Short Interest and Financial Performance of US Bancorp

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Trending

Eli Lilly Stock
AI & Quantum Computing

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

by Felix Baarz
January 11, 2026
0

Eli Lilly and Company has opened 2026 with a clear strategic push to diversify and strengthen its...

Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026
Viking Therapeutics Stock

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

January 11, 2026
Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances
  • Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs
  • Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com